drugset / Trial / NCT00264199

Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure

NCT00264199

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether 48 hours of glucagon-like-peptide-1 (GLP-1) infusion can improve heart function and alter substrate metabolism in non-diabetic patients with heart failure.

Timeline

Start
2005-12
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator GLP-1 Peptide 1 unknown Intravenous